Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PDE5 Inhibition on Adipose Metabolism in Humans
NCT04684589Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in obesity, sponsored by Vanderbilt University Medical Center. Started Mar 2021; status: completed.
02
Drugs
tadalafil
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04684589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684589.